Transcriptomic and genomic analyses in pancretic cancer
Erman Akkus, Medical Oncology Fellow at Ankara University, shared a post on X about a recent paper titled ”Transcriptome-wide association study and Mendelian randomization in pancreatic cancer identifies susceptibility genes and causal relationships with type 2 diabetes and venous thromboembolism.”
Authors: Marcus C.B. Tan, Chelsea A. Isom, Yangzi Liu, David-Alexandre Tregoue, Lang Wu, Dan Zhou, Eric R. Gamazon.
”Transcriptomic and genomic analyses in pancretic cancer.
Which gene expressions are associated with pancreatic cancer risk?
PPIP5K2, TFR2, HNF4G, LRRC10B, PRC1, FBXL20 and previously reported genes INHBA, SMC2, ABO, PDX1, MTMR6, ACOT2, PGAP3, STARD3, GSDMB, ADAM33.
Are there genes in causal relationships with type 2 diabetes and venous thromboembolism?
- Diabetes: HNF4G and PDX1.
- VTE: ABO.”
Source: Erman Akkus/X
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023